Top 50 Health Care Startup Investors in Germany
A list of 50 angel investors and VC funds that invest in Health care startups based in Germany. We rank investors based on the number of investments they made in Health care companies from Germany. We update this investor list every month.Top 50 Health Care Startup Investors in Germany
Investor | Health Care Germany investments |
---|---|
HTGF | High-Tech Gruenderfonds | 66 |
IBB Ventures | 34 |
Atlantic Labs | 25 |
Bayern Kapital | 24 |
Think.Health | 22 |
KfW | 21 |
TGFS - Technologiegründerfonds Sachsen | 18 |
HV Capital | 15 |
Calm/Storm Ventures | 15 |
Boehringer Ingelheim Venture Fund | 14 |
Rheingau Founders | 14 |
APX | 14 |
MIG Capital | 14 |
NRW.BANK | 14 |
b2venture | 14 |
Saarbruecker 21 | 13 |
Wellington Partners | 12 |
DvH Ventures | 12 |
IFB Innovationsstarter | 11 |
Heartcore Capital | 11 |
Carsten Maschmeyer | 10 |
BayBG Venture Capital | 10 |
Brandenburg Kapital | 10 |
seed + speed Ventures | 10 |
bmp Ventures | 10 |
bm-t beteiligungsmanagement thuringen | 10 |
Cherry Ventures | 10 |
coparion | 9 |
Picus Capital | 9 |
Ananda Impact Ventures | 9 |
468 Capital | 8 |
Creathor Ventures | 8 |
Vorwerk Ventures | 8 |
Springboard Health Angels | 8 |
YZR Capital | 8 |
redalpine | 8 |
BioMedPartners | 8 |
Nils Glagau | 7 |
Target Global | 7 |
Heal Capital | 7 |
Ali Ciger | 6 |
Possible Ventures | 6 |
Antler | 6 |
Redstone | 6 |
Ralf Dummel | 6 |
Forbion Capital Partners | 6 |
Amino Collective | 6 |
EQT Life Sciences | 6 |
Headline | 5 |
UVC Partners | 5 |
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Series A, Funding Round
- Germany, Switzerland, United States
Portfolio highlights
- TRAIT — TRAIT Running Coach app for your iphone or ipad tablet.
- DemoSquare — DemoSquare is a pioneer in the realm of public-affairs management connect businesses with government affairs by putting regulatory monitoring on autopilot.
- ABH Optics ApS — ABH Optics provides the world's thinnest and lightest eyeglass lenses.
IBB Ventures is a venture capital and mezzanine arm of Investitionsbank Berlin specializing in seed/startup, early venture, and mid venture investments. The firm invests in technology-oriented companies and companies from the creative industries. It typically invests in information and communication sector with a focus on hardware andsoftware, network technology, new media, and internet and mobile technologies; life science sector with a focus on biotechnology and media technology; and industrial technologies sector with a focus on software, PPS, supply chain management, micro and nanotechnology, environmental and power technology, automation, manufacturing technology, transport technology and logistics, and new materials. The firm also invests in movies, broadcast, television, publisher, music, entertainment, advertising, fashion, design, architecture, multimedia, games, software, and art and culture. It invests in companies based in Berlin. It typically invests between €0.25 million ($0.32 million) and €3 million ($3.83 million) per transaction. The firm prefers to take a board seat in its portfolio companies. IBB Ventures was founded in 1997 and is based in Berlin, Germany.
Show more
Investment focus
- Software, Health Care, Internet
- Seed, Funding Round, Series A
- Germany, United States, United Kingdom
Portfolio highlights
- eco.mio — eco.mio enables companies to reach their climate targets while realizing significant savings: Incentivize employees to travel consciously with eco mio's end-to-end integrated software solution.
- Quantistry — Revolutionize your R&D with QuantistryLab. Explore 100 million structures and run your own simulations from Quantum to AI. Get started today!
- Northbound — We are building the dynamic decision engine that translates real-time data into operational excellence & stakeholder transparency. All at the intersection of warehouse and transport logistics.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Series A, Pre-Seed
- Germany, Switzerland, United States
Portfolio highlights
- Again — SecondCircle makes carbon negative chemicals for a cleaner future. We are the first carbon negative chemical manufacturer that can scale to meet global demand. The best thing about it: we use carbon dioxide as a feedstock.
- SynthFlow AI — Build AI Agents at Scale. No Coding Required.
- SCRYPT Digital — Your trusted partner for crypto assets
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Series A, Funding Round
- Germany, United States, Finland
Portfolio highlights
- planqc — planqc quantum computers store information in individual atoms – nature's best qubits. Quantum information is processed by arranging these qubits in highly scalable arrays and manipulating them with precisely controlled laser pulses. planqc unique combination of quantum technologies is the fastest way to scale to thousands of qubits, aprerequisite for industry-relevant quantum advantage.
- Insempra — Origin.Bio creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialization processes today, but with significantly fewer energy requirements and waste produced while eradicating the need for petrochemicals.The company drives the convergence of engineering with biology, using DNA as theprogramming language. Rather than editing genetic material only in or out of DNA, engineers can hack entirely new organisms that have never existed — all powered by computing, automation, and artificial intelligence (AI)/machine-learning while leveraging millions of years of evolution. Operating at an atomic level, the company farms organisms with microscopic precision and integrates them into existing original equipment manufacturer (OEM) manufacturing processes. This asset-light approach enables Origin.Bio to generate sustainable materials at speed in a cost-effective way, without compromising on performance.
- AVES Reality — We create a VR twin of the world
Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Seed, Series A, Series B
- Germany, United States, Switzerland
Portfolio highlights
- Vara — Vara develops a breast cancer screening platform powered by AI for radiologists, allowing them to focus on finding cancer early. While we provide. Vara also provides remote mammography reading services to those that lack the radiologists. Vara's mission is to make affordable diagnostics available all over the world by designing machinelearning-powered workflows that users love to work with.
- anvajo — Originally started at TU Dresden, anvajo can now look back on several years of innovative research and successful product development with uninterrupted growth. As part of the business expansion and ongoing team building, anvajo moved into its new headquarters in Dresden in January 2020. On 1300 m² practically all areas, including development,production and support functions are united under one roof.
- Navignostics — Navignostics combines highly multiplex tumor imaging with advanced data analytics for personalized cancer treatments.
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more
Investment focus
- Biotechnology, Software, Health Care
- Funding Round, Series A, Series B
- Germany, India, Kenya
Portfolio highlights
- Uniper — Uniper is an international energy company with about 11,000 employees. They combine a balanced portfolio of technologically advanced large-scale assets with outstanding technical and commercial expertise. Uniper is a German energy company based in Dusseldorf, North Rhine-Westphalia. It was formed by the separation of E.ON's fossil fuel assetsinto a separate company that began operating on 1 January 2016.
- Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
- Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more
Investment focus
- Software, Information Technology, Manufacturing
- Seed, Funding Round, Series A
- Germany, United States
Portfolio highlights
- In.hub — in.hub is a specialist in condition monitoring of machines, processes, and products, offering digitalisation options in the industrial environment. It connects legacy and modern systems, creates condition monitoring systems, and generates information for optimal planning and control.
- Packwise — Packwise is bringing Intermediate Bulk Containers (IBCs) to the Internet of Things. Their Packwise Smart Cap makes a container intelligent and allows for improved and automated packaging management and logistics. Millions of IBCs are being used by chemical, pharmaceutical and food companies every day. Their Packwise Smart Cap is narrow-band LPWANconnected and provides users with real-time information on the state and location of containers.Packwise develops ready-to-use web applications and can be integrated with existing in-house IT or software through web service API.Packwise GmbH is a German company based in the Silicon Saxony. Packwise is Europe’s pioneer in digital industrial packaging management (IBCs and drums).
- watttron — Watttron invents a revolutionary heating system that can heat up surfaces heterogeneously.Watttron develops an innovative heating technology that can be used in various industrial processes. It is superior to current heating systems in many ways and offers a number of advantages. On the following pages, you will find information about possibleapplications and opportunities.The company is located in the Technologie- und Gründerzentrum Freital – a technology and start-up center on the outskirts of Dresden, the state capital of Saxony.
We support exceptional founders in building market leading digital companies.
Show more
Investment focus
- E-Commerce, Internet, Software
- Series A, Seed, Series B
- Germany, United Kingdom, United States
Portfolio highlights
- Delli — We're a company just starting out on our mission to make good food accessible and enjoyed by all.
- Again — SecondCircle makes carbon negative chemicals for a cleaner future. We are the first carbon negative chemical manufacturer that can scale to meet global demand. The best thing about it: we use carbon dioxide as a feedstock.
- Bioniq — Bioniq offers a data-driven approach to disease prevention and health promotion. To do this, the company has created a digital platform that aggregates and analyzes data from blood tests, genetic tests and microbiota tests using AI over time.
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more
Investment focus
- Health Care, Wellness, Software
- Seed, Pre-Seed, Series A
- Germany, United Kingdom, Austria
Portfolio highlights
- Propcorn — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
- Linq — The safest way to send intimate content
- Meela — Meela AB matches individuals with psychologists or psychotherapists for online and in-person therapy.
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, Belgium
Portfolio highlights
- Actym Therapeutics, Inc. — Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
- Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
- Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.
Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.
Show more
Investment focus
- Software, E-Commerce, Internet
- Seed, Series A, Pre-Seed
- Germany, United States, Poland
Portfolio highlights
- NetBird — Wiretrustee is an open-source VPN platform built on top of WireGuard® making it easy to create secure private networks for your organization or home. It requires zero configuration effort leaving behind the hassle of opening ports, complex firewall rules, VPN gateways, and so forth.
- MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
- Akhetonics — Creating the first all-optical RISC Processor
APX is Europe’s leading very-early-stage VC. Based in Berlin and backed by Axel Springer and Porsche, we support and partner with the most ambitious founding teams from Europe and beyond - often as their first investor.We invest up to EUR 500K in startups until a series A starting with a quick EUR 50K investment, and within a few months,depending on traction and speed, we can invest further. Each month we invest in new teams who become part of the APX community, counting hundreds of other founders. Since 2018, we have invested in 100+ startups across 20+ industries with founders from 20+ countries together with 100+ co-investors.
Show more
Investment focus
- Software, SaaS, Information Technology
- Pre-Seed, Seed, Series A
- Germany, United Kingdom, United States
Portfolio highlights
- Spike Technologies — November 30, 2022 - Spike technology, REST API end-points, and Cloud architecture are designed with data privacy and security at heart. We process billions of
- Eleos — Get income protection insurance online with Eleos. All policies include 24x7 Virtual GP, gym discounts and other benefits.
- DC Connected — Mobility Enhancement Platform
Zusammen gestalten wir die Unternehmen von morgen.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Germany, France, Austria
Portfolio highlights
- HawkCell — A plug-and-play solution turning human MRI into the first animal-dedicated imaging enhanced with AI algorithms. A unique MRI solution.
- Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
- Innatera — Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.
NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
Show more
Investment focus
- Biotechnology, Software, Information Technology
- Seed, Series A, Series B
- Germany, United States, United Kingdom
Portfolio highlights
- widu — widu enables real estate and accommodation companies to source visuals (photography, video, drone) at scale through its serviced marketplace
- Black Semiconductor — Black Semiconductor manufacture microchips with integrated electronic-photonic circuits using graphene technology.
- Prothea Technologies — Prothea Technologies is a private medical technology business to provide lung cancer biopsy and therapy in a single hospital visit.
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more
Investment focus
- Software, Health Care, Information Technology
- Series A, Seed, Series B
- Germany, Switzerland, United Kingdom
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- Orus Energy — Orus Energy leverages the power of AI to unlock potential of electrical flexibility in commercial buildings.
- SamanTree Medical — SamanTree Medical has developed the Histolog Scanner, a confocal microscopy device intended for imaging the surface of excised human tissue specimens to visualize morphological microstructures. Easy-to-read images are available immediately, providing decision-making support at the point of care.
They are a group of friends and internet/tech entrepreneurs who first met ten years ago in Saarbruecker Strasse 21 in Berlin Prenzlauer Berg. All of them started successful businesses, they are founders and share a passion for building great companies. As active business angels, they also invest in young startups, either individually orcollectively as a group. They provide seed funding for killer-founders and great ideas. But way more important: they help to avoid mistakes that they have already made . They introduce to the right people. They provide with all the experience that they have. Not just talking about it but helping hands-on.
Show more
Investment focus
- Software, Internet, E-Commerce
- Seed, Pre-Seed, Angel
- Germany, United States, Israel
Portfolio highlights
- Floy — Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases.One of Floy’s distinguishing features is our innovative incentive structure. We partnerwith radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption.Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
- a2zebra — a2zebra is a zebra company that specializes in instructional technology for elementary school kids.
- Seqstant — Seqstant offers the LiveGene platform for real-time pathogen analysis, allowing for sensitive, specific, and user-friendly real-time genetic diagnostics.
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Funding Round
- Germany, United States, United Kingdom
Portfolio highlights
- UroMems — The device is developing an active implantable medical device based on the cutting edge technologyl in the field of embedded systems and micro-technologies for the development of its products.
- Minervax — We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.
- Onward — Working to restore movement, independence, and health in people with spinal cord injury.
Investing early in Europe's most passionate founders.
Show more
Investment focus
- Health Care, Financial Services, Software
- Seed, Series A, Funding Round
- Germany, Austria, United Kingdom
Portfolio highlights
- LiveEO — LiveEO is the leading solution provider for AI-powered satellite-based monitoring of large infrastructure networks. Trusted worldwide.
- OneTwenty — OneTwenty is an early-stage health tech start-up that develops multiple Machine Learning based solutions for people with diabetes as well as Medtech companies for sensor optimization, biomarker prediction, glucoregulatory models, and iAGC (interoperable automated glycemic controller). Our solution demonstrates unprecedented precision in bloodglucose prediction 120 minutes in advance. OneTwenty revolutionizes the life of people with Type 1 diabetes.
- HealthCaters — HealthCaters is a connected care solution for companies that allows them to empower their employees to take control of their health.
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Funding Round, Grant
- Germany, United States
Portfolio highlights
- 3D Spark — Profitability and Sustainability Aligned using 3D Spark's Platform - Empowering Manufacturing with Insights and Efficiency!
- Stargazr — Stargazr is a AI-powered software that enables you to understand your financial data
- Neuralfinity — Neuralfinity provides computer AI services. They generalise machine learning models by utilising an ML API as a service.
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Seed, Series A, Series B
- Denmark, Germany, United States
Portfolio highlights
- Skynopy — Connecting satellites. As a service
- MAJORITY — MAJORITY is the first digital financial service dedicated to serving migrants worldwide. For $5 a month, MAJORITY members in the U.S. receive an FDIC-secured account, VISA® debit card, use of more than 55,000 ATMs across North America, remittance and international calling, native language advisors, and access to our network of community meet-upspaces, local discounts and events. With MAJORITY, there are never overdraft fees or minimum balance requirements. MAJORITY was started in Sweden by a diverse team of banking, fintech, payments, and telecom executives serving immigrant communities globally for the last 15 years. MAJORITY’s U.S. headquarters are in Houston, Texas.
- Natural Cycles — Natural Cycles birth control is 93% effective with typical use and 98% effective with perfect use. Learn more about hormone-free birth control today.
Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.
Show more
Investment focus
- Software, Apps, Health Care
- Seed, Angel, Funding Round
- Germany, Austria, Sweden
Portfolio highlights
- theblood — We are giving back self-determination, control and specific health conditions to our users through a non-invasive menstrual blood test
- AnimalChat — The messenger app AnimalChat makes communication with pet owners easier and more efficient. It's used to counteract the drastic lack of staff in the animal industry. As veterinarians we know how bad the situation is, but luckily as software specialists we also know how to fix it. With AnimalChat we free up valuable time for businesses andempower them to offer a better digital experience for their customers.
- JobSwop.io — JobSwop.io is the employment software that allows you to find available positions but also filled ones for people looking to move jobs. The features of this app are Salary information, a Watch list, Area search, Integrated chat, Up to three Job profiles in one account, Document management.
Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.
Show more
Investment focus
- Software, Information Technology, Health Care
- Funding Round, Series A, Series B
- Germany, Italy, United States
Portfolio highlights
- memtime — memtime shows you everything you worked on during the day. Each program is recorded so that you can quickly remember. Add-on available for any software. | memtime
- StoryBox — StoryBox provides a Software as a Service solution for businesses to create, share and structure video content to make it searchable. With the system, companies can create and organize smartphone-based videos for any application scenario. Using the app, videos can be created and shared by every employee using templates. The app suggests picturesettings and scene lengths automatically and offers an automated creation which includes corporate design. The content can be stored in the DSGVO-compliant StoryBox cloud and can be accessed, filtered and analyzed from anywhere. Customers include Iveco, Erste Group, Evonik, Alten, and KTM.
- Kloster Kitchen — Kloster Kitchen is a monastery kitchen as the root of unique taste.
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Funding Round
- Germany, United Kingdom
Portfolio highlights
- Dryad Networks — Overview of Dryad, providing ultra-early fire detection as well as forest growth and health monitoring.
- Mateo — Mateo is the omni-channel customer experience powerhouse that empowers local brands and businesses to drive growth through a digital customer lifecycle management. From acquiring new leads, converting them into customers and extending those relationships - all in one platform.
- Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
Empowering visionary founders with pre-seed and seed funding for B2B software innovation. Partner with us to turn your aspirations into thriving businesses. Our expert support ensures your journey to success.
Show more
Investment focus
- Software, SaaS, Health Care
- Seed, Pre-Seed, Series A
- Germany, Austria, Switzerland
Portfolio highlights
- mogenius — mogenius radically simplifies cloud infrastructure for software developers. The code to cloud platform provides a completely automated workflow of deploying an application in Kubernetes - with hyperscale cloud resources, built-in CI/CD and DDoS protection so you can start coding in seconds. Never waste time on complicated, error-prone, andrepetitive configurations in your cloud infrastructure again, and focus on what you really love: building great applications.
- happyhotel — The happyhotel revenue and yield management system has a simple dashboard that supports the hotelier in the data analysis of the most important hotel KPI’s. happyhotel is a cloud-based hotel software specially designed for small and medium-sized hotels. Hoteliers can achieve more revenue without a great deal of prior knowledge. The hotelier getpast, current and future values of RevPar, Occupancy, ADR and Revenue. Through the booking pace graph and the on the books evaluation the hotelier can react to the current market conditions. Furthermore the hotelier can review every day the important reports and get an alert if the values do not correspond with the budget. happyhotel use a special formula and an algorithm who gives the hotelier the best price recommendation for his hotel or each of your hotel segments and room types. With an interface to the hotel pms happyhotel get all data to analyze the hotel. happyhotel facilitates the hotelier's life through automatic processes so that he can concentrate on other things.
- Helio — Carbon Aware Cloud Computing.
bmp Ventures is an innovative Venture Capital Company from Berlin.
Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more
Investment focus
- Information Technology, Software, Manufacturing
- Seed, Funding Round, Series A
- Germany, United States, Austria
Portfolio highlights
- Neotiv — Enabling cognitive health
- RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
- XenoPatch GmbH — First-ever portable device for pain management, seamlessly combines heat, cold and vibration treatment with an intuitive smartphone app.
bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Funding Round, Series A
- Germany, United States
Portfolio highlights
- rooom.com — rooom is a global startup based in Germany, launched in 2019. The company’s experienceCloud is an all-in-one platform for creating, managing and promoting engaging 2D, 3D, AR & VR experiences. It works across all desktop and mobile devices. rooom’s experienceCloud is designed to cover the marketing and visualization needs of differentindustries through their comprehensive product portfolio. These include eventCloud (optimized for virtual events, exhibitions, conferences, meetings), spaceCloud (real estate, property, museums), productCloud (3D products, product showrooms) and immerseCloud (tours, guides, 3D books). rooom’s eventCloud is routinely hosting up to 200,000 users for hybrid events like IFA, Berlin and for global customers such as Porsche, Deutsche Telekom, DHL and E.ON. rooom has won over 20 awards, including the Global Eventex Award (twice), the Innovation & Excellence Award and the German Innovation Award.
- tediro — tediro develops a mobile robotics platform for multiple applications in healthcare primarily therapy and diagnostics
- Coachwhisperer — Coachwhisperer: The live communication system for sports. We take training to the next level and help coaches and athletes reach their true potential.
Cherry Ventures is an early-stage venture capital firm led by a team of entrepreneurs with experience building fast-scaling companies such as Zalando and Spotify. The firm backs Europe's boldest founders, usually as their first institutional investor, and supports them in everything from their go-to-market strategy and the scaling of theirbusinesses. Cherry Ventures has previously invested in the seed stage of over 50 companies across Europe, including FlixBus, Auto1 Group, Infarm, Rows, Forto, and TourRadar. Cherry Ventures is based in Berlin and invests across Europe with operations in London, Paris, and Stockholm.
Show more
Investment focus
- Software, Financial Services, Information Technology
- Seed, Series A, Series B
- Germany, United Kingdom, United States
Portfolio highlights
- Rows — Combine the power of a spreadsheet with built-in integrations from your business apps. Automate workflows and build tools that make work simpler.
- Swap — Shipping, tracking, package-protection, returns & cross-border all from one dashboard. This is ecommerce evolved.
- bunch — bunch is the operating system (OS) for private market investing, handling digital entity creation, seamless investor onboarding and portfolio management. The company's platform focuses on saving time, money and mental energy by eliminating legacy intermediaries, overwhelming regulatory complexity, and low-tech administration.Operating acrosslegal structures, asset classes and jurisdictions allows bunch to fully unlock private markets for everyone, enabling businesses and investors to make private markets easy, cost-efficient and fast.
Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.
Show more
Investment focus
- Software, SaaS, FinTech
- Series A, Seed, Series B
- Germany, Switzerland, United States
Portfolio highlights
- Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more
Investment focus
- Financial Services, FinTech, Software
- Seed, Series A, Pre-Seed
- Germany, United States, United Kingdom
Portfolio highlights
- Alvys — Alvys is a cloud-based transportation management system with high-tech automation. Specializing in workflow efficiency for small to mid-size carriers. Alvys stands out by saving carriers and freight brokers more time per load than any other TMS! Save up to 30 minutes per load, organize your operations in one place, scale with ease and integrateall your favorite tools. The proof is in the workflows and here's a sneak peek of our popular features:• Driver App • Tracking & Tracing • Source for Truck Capacity • End-to-End Visibility • One Click Accounting • Analytics & Reporting • Safety & Maintenance • Integrations • Benefits for BrokersTRY US FOR FREE! www.alvys.com
- Blitzy — You Describe It, We Build It
- Greptime — From IoT edge data storage to fully-managed cloud data platform, Greptime provides cloud-scale, fast and efficient Time Series Data Infrastructure.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more
Investment focus
- Health Care, Software, Information Technology
- Seed, Funding Round, Series A
- Germany, United Kingdom, Finland
Portfolio highlights
- Ovom Care — Enabling every individual to become a parent.
- Quantistry — Revolutionize your R&D with QuantistryLab. Explore 100 million structures and run your own simulations from Quantum to AI. Get started today!
- Decade Energy — Decade is the energy transition partner for fleet operators and depot managers looking to deploy an electric fleet.
468 Capital is a Berlin and San Francisco based technology investment firm. We support leading software, AI and internet growth companies across multiple investment stages.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Pre-Seed
- Germany, United States, Singapore
Portfolio highlights
- Cartken — Launch your robot fleet with us. The AI powering our robots makes them the safest and most reliable in the market today.
- KARRI — KARRI is a data and GPS enabled, screen-free device for easy communication between you and your kids. A KARRI for your child and a smartphone app for you - it's as simple as that.
- Codesphere — Codesphere is your Zeroconfig Cloud. No config - just code and run web apps from your browser. Team work on distributed full stack Typescript, and benefit from our automatic deployments, scaling, tests, and security / privacy audits. We optimize each and every detail to keep things simple for you. Codesphere is next level programming.
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Series A, Funding Round, Series B
- Germany, Switzerland, United States
Portfolio highlights
- Ledgy — Digitize your cap table, automate equity plans and simplify compliance. Find out how leading companies use Ledgy to empower their employees and engage investors.
- HeyJobs — Intelligent recruiting | more hires with performance marketing | only qualified candidates | fast recruiting success | over 1,500 companies use HeyJobs to find employees
- Humanoo — HUMANOO | MAKING PEOPLE HEALTHIER! HUMANOO is the digital health platform for employees and insurance clients. We enable our users to improve their physical and mental health. Simple, effective, proven - all in one app. With customized programs and innovative eHealth solutions, we guide our users in the areas of fitness, physio, yoga, mindfulnessand nutrition to their self-imposed goals. For the first time, companies and insurance companies can use comprehensive decentralized analysis to understand the health of their employees or insurance clients and make it a measurable success. Our team currently consists of 65 employees from 15 nations with different talents. In our office in Berlin-Kreuzberg, software developers, designers, marketing and sales specialists work together with sports and nutrition scientists as well as yoga teachers and physiotherapists. What we share is the goal to motivate people to stay healthy.
Vorwerk Ventures is an independent €150m Venture Capital Fund grown out of the Vorwerk Group in late 2019 and defines itself through a strong commitment towards consumer-facing digital businesses. Our unique direct selling experience in addition to an outstanding track record in Venture Capital provides added value for forward-thinkingentrepreneurs. Headquartered in Berlin Germany, we currently have more than €250m in assets under management and are constantly on the look-out for promising opportunities starting with Seed/Series A investments of €1m to €10m and ensuring continuous support reserving up to €15m for upcoming financing rounds. An outstanding founding team, an existing market presence and a well-defined exit strategy framed by a consumer-centric business model are key requirements to us when it comes to making an investment decision.
Show more
Investment focus
- E-Commerce, Health Care, Food and Beverage
- Seed, Series A, Series B
- Germany, United Kingdom, Switzerland
Portfolio highlights
- Sunhero — Sunhero delivers custom-built solar panel solutions. Sunhero offers consumers a hassle-free method of installing customised photovoltaic solar systems on their homes, be that either purchasing outright or renting for a 20 year period.
- CarbonPool — Innovative carbon credit insurance which pays claims in carbon credits, not cash. See how we can help you.
- Sorella Care — Sorella is the first network of multidisciplinary health places for women. Sorella ensures that every woman, regardless of age, has access to a comprehensive care pathway offered by women's health specialists.
Springboard Health Angels is a Berlin based Angel group to invest in early stage Digital Health startups
Show more
Investment focus
- Health Care, Software, Biotechnology
- Seed, Pre-Seed, Funding Round
- Germany, United States, Sweden
Portfolio highlights
- deepeye — 66% of blindness in Europe and the US is caused by retinal diseases - and thus preventable.
- PharmaCCX — Welcome to CCX - digital tools purposely-built for market access. Explore our 4 transformative tools, and industry-leading expertise.
- Every Health — Every Health focuses on "holistic, needs-based medical care for the LGBTQIA+ community".
YZR Venture Capital is a vertical Venture Capital Fund backing Health Tech Entrepreneurs.
Show more
Investment focus
- Health Care, Software, Artificial Intelligence
- Seed, Pre-Seed, Funding Round
- Germany, Poland, Finland
Portfolio highlights
- Deemea — Deemea is a collaborative AI platform that connects and provides services for the analysis of medical data for physicians. It uses its expertise in clinical research, data science, and software development to help healthcare professionals.
- Clare&me — Clare is your virtual coach which calls you whenever you want and wherever you are. Stigma free phone calls and messaging based on cognitive- behavioral therapy. clare&me supports you on your self-help journey to better sleep, less worry and more self-confidence.
- Esper Bionics — Solutions to transform the prosthetic industry and augment humanity
redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Series A, Seed, Series B
- Germany, Switzerland, United Kingdom
Portfolio highlights
- Lakera AI — Lakera Guard empowers organizations to build GenAI applications without worrying about prompt injections, data loss, harmful content, and other LLM risks. Powered by the world's most advanced AI threat intelligence.
- ExpressionEdits — Redefining the status quo of protein expression
- Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- Switzerland, Germany, France
Portfolio highlights
- Tricares — TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Nils Glagau
Show more
Investment focus
- Food and Beverage, Food Processing, Personal Health
- Angel, Seed, Pre-Seed
- Germany, Austria, United States
Portfolio highlights
- Zeedz — Gaming for a green future. Zeedz is a monster collectible game that targets real-world climate change. Discover a world of plantified magic, made in Berlin.
- BIOTherma-Pad — BIOTherma-Pad is a completely biological cooling pad made of seaweed rather than the typical chemicals; it may cool little children's injuries or offer warmth if needed.
- Taste Religion — Taste Religion offers plant-based products that are devoid of toxic ingredients and allow to quickly create restaurant-quality cuisine.
Target Global is a prominent European technology investment firm with a significant presence in the venture capital landscape, boasting over €3 billion in assets under management. The firm operates out of key tech hubs including London, Berlin, Tel Aviv, and Abu Dhabi, and has a rich portfolio featuring some of Europe's most successful techcompanies such as Revolut, Auto1, Copper, Delivery Hero, Docplanner, and Rapyd.Founding and GrowthTarget Global was established in 2015 by Shmuel Chafets and Yaron Valler, who brought a wealth of experience from their tenure at Hasso Plattner Ventures. Their professional partnership dates back 15 years to their time at Giza Venture Capital, a trailblazer in Israel's investment ecosystem, where they honed their investment acumen and industry foresight.Investment Philosophy and ImpactTarget Global stands out in the European tech industry for its diverse team and its ability to identify and capitalize on unique opportunities. The firm's knack for recognizing potential in the early stages of Germany's tech economy led to the emergence of several unicorns in the 2010s. As the European tech industry evolves, Target Global remains at the forefront, seeking out innovative companies like Robovision, Saleor, and Finom. These recent investments reflect the firm's commitment to supporting cutting-edge technology and business models.Fundraising SuccessesTarget Global's fundraising prowess is evident in its six investment funds, which have collectively raised significant capital. The funds range from Early Stage Funds, focusing on nascent startups, to Growth Funds that support more mature companies scaling their operations. The firm's co-investment strategy has led to over €1 billion in capital deployment across a diverse array of partnerships.Backing and AchievementsWith the backing of investors such as FERI, UBS, Allianz X, Mubadala, and Hermes GPE, Target Global has cemented its reputation as a trusted and successful investment firm. Its portfolio spans over 140 companies at various development stages, with a focus on those targeting trillion-dollar markets.Just a few of the many notable companies in the firm’s portfolio include:- Tarabut, MENA’s leading open banking platform, which was recently featured in Forbes Middle East’s list of Top 50 Fintech Companies.- Flo Health, an AI-driven women’s health product, which is the world’s top health and fitness app by downloads.- Robovision, an easy-to-use AI-driven computer vision platform for users to develop their own deep-learning-based solutions.- Enter, a German company that helps homeowners and businesses reduce their carbon footprint.Target Global's track record includes support for 15 unicorn companies, over 20 exits, and 7 IPOs, showcasing its ability to drive growth and success in the European tech ecosystem. The team, comprised of individuals with founder and operator backgrounds, continues to pursue exceptional opportunities to expand the firm's portfolio and influence.Target Global's journey from its inception to its current status as a key player in European venture capital is marked by strategic investments, a commitment to diversity, and a deep understanding of the tech industry's dynamics. With a clear vision for the future, Target Global is poised to continue its role in shaping the next wave of European tech giants.
Show more
Investment focus
- FinTech, Financial Services, Software
- Series A, Seed, Series B
- Germany, Israel, United Kingdom
Portfolio highlights
- Robovision — Take control of your AI vision with Robovision's award-winning platform to manage vision intelligence in smart marchines
- MagnusMetal — Magnus_Metal - Digital Era has arrived for Metal Casting. MagnusMetal team is taking casting, a 6000 years old technology, to the digital Industry 4.0 era, with our breakthrough patent pending, volume alloy Digital Casting System and process
- Saleor Commerce — A headless, GraphQL-first e-commerce platform delivering ultra-fast, dynamic, personalized shopping experiences. Find out why developers love it.
Heal Capital is a European venture capital fund backing mission-driven founders with capital and HealthTech-specific expertise, accelerating market access.
Show more
Investment focus
- Health Care, Artificial Intelligence, Machine Learning
- Seed, Series A, Series B
- Germany, Canada, Poland
Portfolio highlights
- PeakData — PeakData is a software platform to identify and analyze key opinion leaders in your therapeutic area. PeakData is making sense of the data spread across the web by using the latest developments of AI.
- Avi Medical — Avi Medical is a digital health care company that provides telemedicine services. Its platform enables patients to book appointments, manage their health data, and chat with the practitioner. The company uses data-driven medicine to provide patients and healthcare workers with a streamlined, more modern experience.
- Spotlight Medical — Spotlight Medical is a precision medicine company striving to free all patients from cancer through a better understanding of each patient’s unique disease. We develop advanced AI tests that enhance treatment selection by leveraging decades of patient data. This ensures personalized and effective care for each individual, significantly improvingpatient outcomes and quality of life. By closely collaborating with physicians, we create impactful tests that address critical unmet clinical needs, opening a new era in cancer care.
Ali is the Head of Vaccines for Pfizer Germany. He was previously part of the global rollout of the COVID-19 vaccine.
He is investing at early stage Digital Health startups, being part of Sprinboard Health Angels (www.springboardangels.com).
He is also a Newton Fellow, the joint program of London Business School and Local Globe.
Show more
Investment focus
- Health Care, Software, Machine Learning
- Pre-Seed, Seed, Funding Round
- Germany, Switzerland, United Kingdom
Portfolio highlights
- Halitus — Laser Technology x Gas Dynamics Analysis x Machine Learning.
- LEVY Health — Endometriosis is a condition where tissue like your uterine lining grows outside the womb: on the ovaries, fallopian tubes, pelvic tissues, or more rarely, in other parts of the body.
- Every Health — Every Health focuses on "holistic, needs-based medical care for the LGBTQIA+ community".
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Pre-Seed, Series A
- Germany, Australia, United States
Portfolio highlights
- Insempra — Origin.Bio creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialization processes today, but with significantly fewer energy requirements and waste produced while eradicating the need for petrochemicals.The company drives the convergence of engineering with biology, using DNA as theprogramming language. Rather than editing genetic material only in or out of DNA, engineers can hack entirely new organisms that have never existed — all powered by computing, automation, and artificial intelligence (AI)/machine-learning while leveraging millions of years of evolution. Operating at an atomic level, the company farms organisms with microscopic precision and integrates them into existing original equipment manufacturer (OEM) manufacturing processes. This asset-light approach enables Origin.Bio to generate sustainable materials at speed in a cost-effective way, without compromising on performance.
- Sumday — Non - financial accounting software. Start carbon accounting, properly, with the support of your existing advisors
- InSpacePropulsion Technologies — ISPTech is a Spin-Off of the Institute of Space Propulsion at the German Aerospace Center (DLR). It offers non-toxic, green propulsion solutions
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more
Investment focus
- Software, Information Technology, SaaS
- Pre-Seed, Seed, Series A
- Singapore, United Kingdom, Australia
Portfolio highlights
- FitFlo — FitFlo brings to life the connected gym experience for Operators, Trainers and Members.
- Mole — Mole is a digital business card and mobile website software. Connect with your clients, promote your business online and much more. Comes with free customised NFC business card.
- Optacloud — Fostering a global AI powered ecosystem to achieve 100% cloud efficacy-> effortlessly, economically and eco-consciously. Dev tools stack for automating the entire development lifecycle of cloud apps across- Build, Deploy & Optimize.
The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Funding Round
- Germany, Finland, Switzerland
Portfolio highlights
- Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
- Crafthunt — Find your dream job - Discover Crafthunt – Europe's largest platform for construction site jobs.Browse new jobs anonymously without being discovered by your current employer.Discover jobs for site managers, foremen, bricklayers, plant mechanics, and more...Save time in your job search and also be proactively approached by companiesacross 21 languages.Sign up and discover the best engineering offices, construction companies & craft businesses in Europe with Crafthunt!
- Wave Photonics — Wave Photonics utilizes computational techniques to accelerate integrated photonics product designs.The company is developing a platform that provides optimized designs and streamlined integration between the supply chain using a software tool for predicting the performance and variation of a component for a given fabrication process and anoptimizer to generate a foundry-specific component library.Wave Photonics is headquartered in Bristol, Bristol.
Ralf Dummel, born on 02.12.1966 in Bad Segeberg in Germany, started his career on 01.04.1988 at DS Produkte as a sales assistant to the then founder. Over the years he learned the business from the ground and took full responsibility for purchases and sales after only a year. He vastly participated in the establishment of the company and has been apartner since 1996. Today, the group has an annual turnover of ca. € 250 000 000, 400 employees, and more than 4 000 products in its portfolio. He often travels the world to visit suppliers and customers, and to find inspiration in new innovative products. Dümmel knows Asia inside out, but Northern Germany is the place he calls home. Since 2016 he takes part in the TV program “Die Höhle der Löwen” (literally: The Lions’ Cave, German version of Dragons’ Den on German TV channel VOX ) where he plays one of the “lions”, looking for young entrepreneurs with brilliant products.Ralf Dummel is very convincing with his genuine and appreciative style. From day one, Ralf Dümmel brightened up the surroundings, thanks to his enthusiasm for business and for new products. He has a unique sense for trends and products; he can market them with more success than hardly anyone else. He proudly claims that there hardly is any household without a “DS product” in Germany. Dümmel is often on the road for professional reasons, and when he sees that a customer adds a DS product in their shopping cart, he feels the same tingle of joy after 28 years that he felt in the early days. The 400 employees are Dümmels’s most important asset. They actively take part in the company, invest themselves in it, and help it develop further. Dummel is very proud that the DS products are the result of such a varied cast of people and skill sets. These are people with different personalities and talents that complement each other in a cooperation shaping always innovative business and product ideas.
Show more
Investment focus
- Food and Beverage, Manufacturing, Product Design
- Angel, Seed, Funding Round
- Germany, United States, Switzerland
Portfolio highlights
- Zeedz — Gaming for a green future. Zeedz is a monster collectible game that targets real-world climate change. Discover a world of plantified magic, made in Berlin.
- Frinsh — Many ready-to-drink ginger shots are sweetened or blended with fruit juice and thus contain a lot of sugar. The Frinish Ginger Cubes, on the other hand, is made entirely with ginger. Our fresh ginger is processed into a fine ginger puree and then frozen promptly. This implies that the flavor and nutrients are kept better.
- TeaBlobs — TeaBlobs allows you to make tea fast, responsibly, and without using a bag. Now available in seven delectable flavors.
Impacting the future of medicine.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
- Navigator Medicines — Leading the advancement of biologics for targeted immune regulation & restoration.
- Bicycle Therapeutics — Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Seed, Series A, Pre-Seed
- United States, Germany, United Kingdom
Portfolio highlights
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- ExpressionEdits — Redefining the status quo of protein expression
- Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, The Netherlands, Switzerland
Portfolio highlights
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- Binx Health — Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer
- Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.
Headline is a Venture Capital firm actively on the ground in 7 cities around the world. We invest across categories and geographies, leading rounds at every stage. Once we commit to a team, we go to the ends of the earth to make their success global.
Show more
Investment focus
- Software, E-Commerce, Information Technology
- Series A, Series B, Seed
- United States, Germany, United Kingdom
Portfolio highlights
- Mistral AI — Frontier AI in your hands
- Gorilla — We empower Energy Retailers in pricing, forecasting and reporting with data-driven solutions in boosting speed and flexibility.
- Natural Cycles — Natural Cycles birth control is 93% effective with typical use and 98% effective with perfect use. Learn more about hormone-free birth control today.
UVC Partners is a Munich- and Berlin-based early-stage venture capital firm that invests in technology-based startups in the areas of enterprise software, industrial technologies, and mobility. The fund typically invests between € 0.5 - 10m initially and up to € 20m in total per company.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Series A, Series B
- Germany, Switzerland, Denmark
Portfolio highlights
- Cyclize — Cyclize enables a carbon circular economy with innovative plasma sources for chemical recycling, CO2-splitting, and gas reforming.
- Reel Energy — Accelerate the transition to a society powered 100% by renewables. Reduce your company's carbon footprint with electricity from new solar parks and wind farms.
- Proxima Fusion — We are a European fusion energy startup pursuing the clearest path to grid deployment.
Investors by industry
Google
Artificial intelligence
Biotech
Climate
Proptech
Consumer
Media (entertainment)
Hardware
Community
Health Care
FinTech
Gaming
Impact
Marketplace
EdTech
Energy
Sustainability
Venture Capital
Agriculture (agtech)
Retail
Fashion
Art
Beauty
Infrastructure
Big Data
Publishing
Email
Food and Beverage
Organic Food
Social Media
Real Estate
Photography
B2B
Web3
Wellness
Oil and Gas
Video Games
Financial Services
Finance
Social Network
Clean Energy
Payments
Education
Fitness
Medical
Travel
Hospitality
Manufacturing
Recruiting
Biotechnology
Mobile Advertising
Internet
Cannabis
Platforms
Music
Social
Crowdfunding
Digital Media
Automotive
Wine And Spirits
Legal
Medical Device
CleanTech
Franchise
Transportation
Mobile Apps
eSports
InsurTech
Enterprise
Local
Android
LGBT
Construction
Enterprise Software
Mobile
Sports
Non Profit
Film
Theatre
Life Science
Renewable Energy
SaaS
Sporting Goods
Restaurants
Celebrity
Software
Social Impact
Cryptocurrency
Facebook
Blockchain
Investors by country
Germany
India
South Korea
Canada
New Zealand
Australia
United Kingdom
United States
Ireland
Japan
Armenia
Brazil
Africa
LATAM
Middle East
Asia
Saudi Arabia
Europe
Singapore
Spain
Vietnam
China
Oceania
Indonesia
Qatar
South Africa
Sri Lanka
Belize
Kuwait
Bahrain
Lithuania
Algeria
Barbados
Hungary
Mali
Philippines
Gibraltar
Costa Rica
Jersey
Myanmar
Ethiopia
Greece
Malta
Finland
Mauritius
Estonia
Nicaragua
Ghana
Italy
Ecuador
Chile
Liechtenstein
Egypt
Kenya
Croatia
Cayman Islands
Georgia
Belarus
Faroe Islands
Denmark
Hong Kong
Israel
France
Liberia
Panama
Belgium
Bermuda
Malaysia
Bulgaria
Czech Republic
Lebanon
Kazakhstan
Tanzania
Norway
Zimbabwe
Slovenia
Tunisia
Russian Federation
San Marino
Ukraine
Cambodia
Morocco
Serbia
Venezuela
Thailand
Zambia
Uzbekistan
Peru
Togo
Uruguay
Tajikistan
Mexico
Senegal
El Salvador
Portugal
Dominican Republic
Sierra Leone
Turkey
Azerbaijan
Poland
Puerto Rico
Namibia
Nigeria
Taiwan
Seychelles
Uganda
Rwanda
Iraq
Sweden
Iceland
United Arab Emirates
Honduras
Bahamas
Isle of Man
Bolivia
Albania
Luxembourg
Pakistan
Bangladesh
Romania
Grenada
Jordan
Argentina
Cameroon
Cyprus
Latvia
Oman
Austria
Switzerland
Colombia
Guatemala
Marshall Islands
Investors in Germany by industry
Enterprise
Biotech
Health Care
Consumer
EdTech
Climate
Impact
Community
Marketplace
SaaS
Agriculture (agtech)
Media (entertainment)
Hardware
Gaming
Energy
Crowdfunding
Venture Capital
Real Estate
Fashion
Transportation
Education
Financial Services
Restaurants
Cryptocurrency
Payments
Finance
Food and Beverage
Video Games
Organic Food
Wine And Spirits
Publishing
Medical
Email
Medical Device
Wellness
Digital Media
Music
Social Media
Manufacturing
Blockchain
Art
Android
Mobile
Construction
Social Impact
Software
Social Network
Local
Legal
Sports
Enterprise Software
eSports
Fitness
Hospitality
Travel
InsurTech
Automotive
Platforms
Mobile Advertising
Cannabis
Retail
Mobile Apps
Infrastructure
Web3
Beauty
B2B
Life Science
Big Data
Photography
Clean Energy
Renewable Energy
Recruiting
Internet
Sustainability
Franchise
Oil and Gas
Proptech
Artificial intelligence
Biotechnology
Social
Sporting Goods
FinTech
CleanTech